By further analyzing the change of ferritin and transferrin saturation (TSAT) with different baseline levels, this study allows understanding of ferric citrate’s iron absorption/utilization and its effects on anemia improvement in ESRD patients with medium level of ferritin, its impacts on existing anemia treatments and long-term safety profile in the clinical practice. The gene discussed is TF; the disease is anemia.